Trade Mark Journal No.2026/043 23 October 2026

WO0000001941773 (5)

Office of origin: United States of America

Date of International Registration:10 September 2026
Date of designation in the UK: 10 September 2026
Image for mark 1941773 CAVHANZA

International priority date claimed: 12 March 2026 (United States of America) (99699122)
Class 5
Pharmaceutical preparations, namely, those for use in human oncology; tyrosine kinase inhibitors for use in the treatment of cancer; drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia.

FLEX PHARMA, LLC

Representative: James A Wahl Lathrop GPM LLP, 80 South 8th Street, 3100 IDS Center, Minneapolis MN 55402, UNITED STATES OF AMERICA